Raltegravir

Details

Files

Generic Name:

Raltegravir

Project Status:

Complete

Therapeutic Area:

HIV (treatment naïve)

Manufacturer:

Merck Frosst Canada Ltd.

Brand Name:

Isentress

Project Line:

Reimbursement Review

Project Number:

SR0191-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV (treatment naïve)

Recommendation Type:

Do not list

Final Recommendation:

June 23, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 4, 2009